Cargando…
Correction: GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis
Autores principales: | Swindell, William R., Bojanowski, Krzysztof, Kindy, Mark S., Chau, Raymond M. W., Ko, Dorothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291644/ https://www.ncbi.nlm.nih.gov/pubmed/32537139 http://dx.doi.org/10.1186/s40035-020-00207-0 |
Ejemplares similares
-
GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis
por: Swindell, William R., et al.
Publicado: (2018) -
A Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with Amyotrophic Lateral Sclerosis (ALS Protocol GALS-001) and a single compassionate patient treatment (Protocol GALS-C)
por: Kindy, Mark, et al.
Publicado: (2017) -
Correction to: Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2023) -
Correction to: 604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases
Publicado: (2022) -
Correction: (1)H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
por: Blasco, Hélène, et al.
Publicado: (2010)